Search

everythinglearnresearchcommunity

for

Search:↓

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride and minoxidil together work best for male hair loss.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Menopause affects hair and skin; more research needed for treatment.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The normal human prostate does not significantly affect blood DHT levels.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

As of 1994, treatments for liver cancer had not significantly improved patient survival.